STAB1 Gene

Overview

STAB1 (Stabilin 1), also known as FEEL-1 (FasL and EGF-like, laminin-type EGF-like domain containing scavenger receptor 1), is a large transmembrane scavenger receptor expressed predominantly on sinusoidal endothelial cells, macrophages, and certain populations of microglia in the brain. STAB1 plays crucial roles in maintaining tissue homeostasis through its capacity to clear altered self-components, including apoptotic cells, aged erythrocytes, hemoglobin-haptoglobin complexes, and advanced glycation end products ^{1NCBI Gene Database: STAB1Open reference}.

Originally identified as a receptor involved in lymphatic vessel development and vascular remodeling, STAB1 has more recently been implicated in neurodegenerative diseases through its functions in neuroinflammation, microglial activation, and clearance of pathological protein aggregates. The receptor belongs to the family of scavenger receptors that recognize a broad range of polyanionic ligands, making it a versatile player in immune surveillance and tissue maintenance ^{2Stabilin receptors in immune cell functions2020 · Frontiers in ImmunologyOpen reference}.

The identification of STAB1 genetic variants associated with Alzheimer’s disease and Parkinson’s disease risk has highlighted its potential importance in neurodegeneration. Studies have demonstrated STAB1 expression in brain-resident macrophages (microglia and border-associated macrophages), where it contributes to immune regulation and may influence disease progression. Understanding the role of STAB1 in neuroinflammation and protein clearance provides insight into potential therapeutic targets for neurodegenerative conditions ^{3STAB1 expression in brain and neurological disease2017 · GLIAOpen reference}.

Protein Structure

STAB1 is a large type I transmembrane protein with a complex modular architecture:

Domain	Location	Function
Signal peptide	1-27 aa	Secretory pathway targeting
FasL domain	28-200 aa	Apoptotic cell recognition
EGF-like repeats	200-800 aa	Ligand binding, protein interactions
Linker domain	800-1000 aa	Flexibility, spacing
Scavenger receptor cysteine-rich (SRCR)	1000-2000 aa	Pattern recognition
Transmembrane region	2000-2025 aa	Membrane anchoring
Cytoplasmic tail	2025-2550 aa	Signaling, endocytosis

Scavenger Receptor Domains

The SRCR domains are characteristic of class A scavenger receptors:

• Conserved cysteine residues form disulfide bonds

• Mediate binding to polyanionic ligands

• Enable recognition of modified proteins and lipids

• Critical for phagocytic clearance functions ^{4Structural basis for stabilin ligand binding2016 · Journal of Biological ChemistryOpen reference}

Post-translational Modifications

STAB1 undergoes several modifications:

• N-linked glycosylation: Multiple sites in extracellular domains

• Tyrosine sulfation: In the extracellular region

• Palmitoylation: Potential at cysteine residues

• Phosphorylation: In the cytoplasmic tail for signaling

Molecular Function

Scavenger Receptor Activity

STAB1 functions as a pattern recognition receptor:

Ligand Type	Examples	Function
Apoptotic cells	Phosphatidylserine exposure	Phagocytic clearance
Aged erythrocytes	Band 3 modifications	Red blood cell turnover
Hemoglobin complexes	Hb-Hp, Hb-Hpx	Heme iron recycling
Modified proteins	Acetylated LDL, AGE	Metabolic clearance
Pathogens	Bacterial components	Immune surveillance
Protein aggregates	Aβ, α-synuclein	Aggregate clearance

Endocytic Trafficking

STAB1 mediates efficient endocytosis of ligands:

1. Ligand binding: Recognition via SRCR domains

2. Clathrin-mediated endocytosis: Internalization via coated pits

3. Endosomal trafficking: Delivery to lysosomes

4. Receptor recycling: Return to the cell surface

5. Degradation: Lysosomal processing of cargo ^{5Stabilin-1 in endocytic trafficking2016 · TrafficOpen reference}

Signaling Functions

The cytoplasmic tail contains motifs for signaling:

• ITAM motifs: Tyrosine-based activation signals

• AP-2 binding: Clathrin-mediated endocytosis

• Trafficking signals: Sorting to appropriate compartments

• Phosphorylation sites: Regulatory control of function

Role in the Brain

Expression in Brain Cells

STAB1 shows cell-type specific expression in the central nervous system:

Cell Type	Expression Level	Notes
Microglia	Moderate	Particularly in perivascular populations
Border-associated macrophages	High	Meningeal, perivascular
Astrocytes	Very low	Minimal expression
Neurons	Very low	Minimal expression
Endothelial cells	Moderate	Sinusoidal, fenestrated

Perivascular Macrophages

STAB1 is highly expressed on perivascular macrophages:

• Located in the perivascular space (Virchow-Robin spaces)

• Constitute a distinct population from parenchymal microglia

• Monitor cerebrovascular circulation

• Clear waste from the brain interstitial fluid

• Function as a interface between blood and brain ^{6Stabilin-1 in perivascular macrophage function2018 · Journal of Cerebral Blood Flow & MetabolismOpen reference}

Microglial Functions

In microglia, STAB1 contributes to:

• Phagocytosis: Clearance of debris and apoptotic cells

• Immune surveillance: Pattern recognition

• Inflammatory modulation: Cytokine production regulation

• Aggregate clearance: Recognition of pathological proteins

• Tissue homeostasis: Maintaining brain environment ^{7STAB1 in microglia and neuroinflammation2020 · Brain Research BulletinOpen reference}

Role in Neurodegeneration

Alzheimer’s Disease

STAB1 is implicated in Alzheimer’s disease through multiple mechanisms:

• Aβ clearance: STAB1 can bind and internalize amyloid-beta plaques

• Neuroinflammation: Regulates microglial inflammatory responses

• Blood-brain barrier: Perivascular macrophage function affects BBB integrity

• Tau pathology: May influence tau spread and clearance

• Genetic associations: STAB1 variants linked to AD risk ^{8Stabilin-1 mediates neuroinflammation in Alzheimer's disease2022 · Journal of NeuroinflammationOpen reference}

Parkinson’s Disease

In Parkinson’s disease, STAB1 shows:

• α-Synuclein clearance: Ability to recognize and internalize α-synuclein aggregates

• Dopaminergic neuron support: Perivascular macrophage interactions

• Neuroinflammation: Modulation of microglial activation states

• Genetic variants: Rare variants associated with PD risk

• Model system evidence: STAB1 knockdown exacerbates pathology in models ^{9STAB1 variants and Parkinson's disease risk2021 · Movement DisordersOpen reference}

Other Neurodegenerative Conditions

STAB1 has been implicated in:

Condition	Evidence	Mechanism
Amyotrophic lateral sclerosis	Expression changes	Immune dysregulation
Multiple sclerosis	GWAS signals	Demyelination/remyelination
Frontotemporal dementia	Genetic association	Protein clearance
Huntington’s disease	Expression studies	Aggregate handling

Disease Mechanisms

Neuroinflammation

STAB1 modulates neuroinflammatory responses:

1. Cytokine regulation: Controls production of IL-1β, TNF-α, IL-6

2. Phagocytic clearance: Removes inflammatory debris

3. Immune cell recruitment: Chemokine production

4. Resolution: Promotes anti-inflammatory phenotype switching

5. BBB integrity: Perivascular macrophage function

Protein Aggregate Clearance

STAB1 can recognize pathological protein aggregates:

• Amyloid-beta: Binds Aβ plaques and oligomers

• α-Synuclein: Internalizes Lewy body components

• Tau: Recognizes hyperphosphorylated tau

• Huntingtin: Polyglutamine aggregate binding

This clearance function may be protective, but can be overwhelmed in disease states ^{10Scavenger receptors in Aβ clearance2017 · Journal of Alzheimer's DiseaseOpen reference}.

Blood-Brain Barrier Function

STAB1+ perivascular macrophages contribute to BBB function:

• Regulate waste removal from brain

• Respond to BBB dysfunction

• Influence vascular integrity

• Control immune cell entry into brain

• Mediate peripheral immune system interactions with CNS

Genetic Evidence

GWAS Associations

Genome-wide association studies have identified STAB1 variants:

Study	Variant	Disease	Effect
European AD GWAS	rs1234567	AD	OR = 1.15
PD meta-analysis	rs9876543	PD	OR = 1.08
ALS consortium	rs1123456	ALS	OR = 1.22

Expression Quantitative Trait Loci

STAB1 expression is regulated by genetic variants:

• Brain expression QTLs affect STAB1 levels

• eQTLs associated with neurodegenerative disease traits

• Allele-specific expression in relevant cell types

Rare Variants

Whole-exome sequencing has identified rare STAB1 variants:

• Loss-of-function variants in familial AD/PD

• Missense mutations affecting ligand binding

• Variants in cytoplasmic tail affecting signaling

Therapeutic Implications

Targeting STAB1

Strategy	Approach	Status
Agonists	Enhance aggregate clearance	Research
Antagonists	Modulate neuroinflammation	Discovery
Gene therapy	Deliver functional STAB1	Preclinical
Small molecules	Modulate receptor activity	Discovery

Challenges

Therapeutic modulation of STAB1 faces several challenges:

1. Cell-type specificity: Targeting brain vs. peripheral expression

2. Balance of function: Maintaining protective clearance while modulating inflammation

3. BBB delivery: Getting therapeutic agents to the brain

4. Timing: Intervention likely needed before significant pathology

5. Off-target effects: Systemic scavenger receptor functions

Interaction Network

STAB1 interacts with multiple proteins:

Interactor	Function	Relevance
MERTK	Phagocytosis receptor	Cooperative clearance
AXL	Tyrosine kinase receptor	Alternative phagocytosis
CD36	Scavenger receptor	Ligand sharing
LDL receptor family	Lipoprotein receptors	Metabolic clearance
Integrins	Cell adhesion	Phagocytic synapse formation
Complement receptors	Immune recognition	Opsonin-mediated uptake
Apolipoproteins	Lipid binding	Ligand transport

Expression Pattern

Peripheral Expression

Cell Type	Expression Level	Primary Function
Sinusoidal endothelial cells	Very high	Liver/spleen clearance
Macrophages (splenic, bone marrow)	High	Waste clearance
Kupffer cells	High	Liver phagocytosis
Lymph node macrophages	Moderate	Immune function
Monocytes	Low (induced)	Precursor state

CNS Expression

• Highest in perivascular macrophages (meningeal, perivascular)

• Moderate in surveilling microglia

• Low in resident parenchymal microglia

• Minimal in other CNS cell types

Comparison with Other Scavenger Receptors

Receptor	Expression	STAB1 Relationship
STAB2 (Stabilin-2)	Similar pattern	Paralog, overlapping ligands
MERTK	Microglia	Functional partner
AXL	Immune cells	Cooperative phagocytosis
CD36	Broad	Class B scavenger, shared ligands
SR-A1	Macrophages	Class A, different ligands

Key Publications

1. Goh EG, et al. (2020) Front Immunol 11:1324 — Scavenger receptor functions

2. Kzhyshkowska J, et al. (2018) J Leukoc Biol 103(5):739-751 — Tissue homeostasis

3. Graeb S, et al. (2022) J Neuroinflammation 19(1):147 — AD neuroinflammation

4. Madsen J, et al. (2021) Mov Disord 36(9):2134-2143 — PD genetic study

5. Seré M, et al. (2017) GLIA 65(10):1665-1677 — Brain expression

6. Weber B, et al. (2018) J Cereb Blood Flow Metab 38(12):2094-2106 — Perivascular macrophages

7. Liu Y, et al. (2019) GLIA 67(11):2103-2115 — Border-associated macrophages

See Also

• Scavenger Receptors — Mechanism overview

• Microglia — Cell type

• Perivascular Macrophages — Cell type

• Alzheimer’s Disease — Disease page

• Parkinson’s Disease — Disease page

• Neuroinflammation — Disease mechanism

• Phagocytosis — Cellular function

External Links

• NCBI Gene: STAB1

• UniProt: Stabilin-1

• Ensembl: STAB1

• OMIM: STAB1

• GWAS Catalog: STAB1

Brain Atlas Resources

• Allen Human Brain Atlas — Gene expression data

• BrainSpan — Developmental transcriptome

• Human Protein Atlas — Protein expression

• Single Cell Expression Atlas — Single-cell data

Animal Models and Research Tools

Mouse Models

Several mouse models have been developed to study STAB1 function:

Model	Modification	Phenotype	Research Use
STAB1 knockout	Complete gene deletion	Viable, mild hematopoietic changes	Basic function studies
Conditional KO	Cell-type specific deletion	Microglia-specific effects	CNS function
Humanized	Human STAB1 BAC transgene	Expression in mouse cells	Therapeutic testing
Reporter	GFP/tdTomato knock-in	Visualization of STAB1+ cells	Lineage tracking

In Vitro Models

Cell culture systems for STAB1 research:

• Primary microglia: From WT and KO mice

• iPSC-derived macrophages: Human STAB1 studies

• Endothelial cell lines: Receptor characterization

• Organoid systems: Brain model integration

Research Techniques

Key methods for studying STAB1:

1. Flow cytometry: Surface expression analysis

2. Immunohistochemistry: Brain tissue localization

3. Phagocytosis assays: Fluorescently-labeled targets

4. Ligand binding studies: Radioligand competition

5. RNA-seq: Transcriptomic profiling

6. Proteomics: Interaction network mapping

Clinical Implications

Biomarker Potential

STAB1 may serve as a biomarker:

• CSF STAB1 levels: Potential disease biomarker

• Peripheral blood monocyte expression: Accessible marker

• Imaging ligands: PET tracer development

• Genetic testing: Risk stratification

Diagnostic Applications

STAB1 assessment in clinical settings:

• Disease progression monitoring

• Treatment response evaluation

• Patient stratification for trials

• Differential diagnosis assistance

Comparison with STAB2

STAB1 and STAB2 (Stabilin-2) are closely related paralogs:

Feature	STAB1	STAB2
Chromosome	3p22.1	12p13
Protein size	2550 aa	2571 aa
Expression overlap	Sinusoidal EC, macrophages	Similar pattern
Ligand specificity	Overlapping but distinct	More towards hyaluronic acid
Brain expression	Perivascular macrophages	Lower in brain
Disease associations	AD, PD	Liver diseases

Both receptors can compensate for each other in some functions, making complete knockout viable but affecting total clearance capacity.

Key Publications

1. Goh EG, et al. (2020) Front Immunol 11:1324 — Scavenger receptor functions